Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nawel Zaibi"'
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247234 (2021)
Elevated reactive oxygen species (ROS) in type 2 diabetes cause cellular damage in many organs. Recently, the new class of glucose-lowering agents, SGLT-2 inhibitors, have been shown to reduce the risk of developing diabetic complications; however, t
Externí odkaz:
https://doaj.org/article/85a3d9e368ef4bcd8f097f9b74fbd736
Autor:
Nawel Zaibi, Gui-Lan Chen, Thomas Hallett, Bo Zeng, Shang-Zhong Xu, Rahul Saurabh, Pengyun Li, Hussein N. Rubaiy
Publikováno v:
Br J Pharmacol
British Journal of Pharmacology
British Journal of Pharmacology
BACKGROUND AND PURPOSE: Mibefradil, a T‐type Ca(2+) channel blocker, has been investigated for treating solid tumours. However, its underlying mechanisms are still unclear. Here, we have investigated the pharmacological actions of mibefradil on Ora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df90a501669df1fabf8f529c3eaccb3e
https://doi.org/10.1111/bph.14788
https://doi.org/10.1111/bph.14788
This protocol is for the detection of cytosolic and mitochondrial ROS using FlexStation 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::548505f8e748d587364e9d36d0712fed
https://doi.org/10.17504/protocols.io.bsb2naqe
https://doi.org/10.17504/protocols.io.bsb2naqe
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 2, p e0247234 (2021)
PLOS ONE
PLoS ONE, Vol 16, Iss 2, p e0247234 (2021)
PLOS ONE
Elevated reactive oxygen species (ROS) in type 2 diabetes cause cellular damage in many organs. Recently, the new class of glucose-lowering agents, SGLT-2 inhibitors, have been shown to reduce the risk of developing diabetic complications; however, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862144bc2c79746300fbc6a5bbedf35b
http://europepmc.org/articles/PMC7894948
http://europepmc.org/articles/PMC7894948